These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 9093386)

  • 1. Micronucleated cells during the growth of the Ehrlich ascites tumour on spontaneous and by titanocenedichloride-induced conditions.
    Tarillion P; Taubert G; Nenning H
    Mutat Res; 1997 Mar; 389(2-3):213-8. PubMed ID: 9093386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitumour activity of [1,2-di(cyclopentadienyl)-1,2-di(p-N,N-dimethylaminophenyl)-ethanediyl] titanium dichloride in xenografted Ehrlich's ascites tumour.
    Valadares MC; Ramos AL; Rehmann FJ; Sweeney NJ; Strohfeldt K; Tacke M; Queiroz ML
    Eur J Pharmacol; 2006 Mar; 534(1-3):264-70. PubMed ID: 16513106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of cell arrest at G1/S and in G2 after treatment of Ehrlich ascites tumor cells with metallocene dichlorides and cis-platinum in vitro.
    Köpf-Maier P; Wagner W; Liss E
    J Cancer Res Clin Oncol; 1983; 106(1):44-52. PubMed ID: 6684118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunologic response to the treatment of Ehrlich ascites tumor with titanocene dichloride.
    Köpf-Maier P; Hesse A
    J Cancer Res Clin Oncol; 1984; 108(2):254-5. PubMed ID: 6540782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokinetic behavior of Ehrlich ascites tumor after in vivo treatment with cis-diamminedichloroplatinum(II) and metallocene dichlorides.
    Köpf-Maier P; Wagner W; Liss E
    J Cancer Res Clin Oncol; 1981; 102(1):21-30. PubMed ID: 7199526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Titanocene dichloride--the first metallocene with cancerostatic activity.
    Köpf H; Köpf-Maier P
    Angew Chem Int Ed Engl; 1979 Jun; 18(6):477-8. PubMed ID: 111586
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of a Titanocene Dichloride derivative, Ti IV (C5H5)(2) NCS(2), on the haematopoietic response of Ehrlich tumour-bearing mice.
    Valadares MC; Queiroz ML
    Eur J Pharmacol; 2002 Mar; 439(1-3):35-42. PubMed ID: 11937090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro cell growth inhibition by metallocene dichlorides.
    Köpf-Maier P; Wagner W; Köpf H
    Cancer Chemother Pharmacol; 1981; 5(4):237-41. PubMed ID: 7261252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early effects of cis-dichlorodiammine platinum (II) on tumor progression and programmed death of Ehrlich ascites carcinoma cells.
    Razin BV; Inzhevatkin EV; Nefedova VV; Egorova AB; Kazbanov VI; Nefedov VP
    Bull Exp Biol Med; 2001 Jun; 131(6):568-9. PubMed ID: 11586409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carboplatin treatment induces dose-dependent increases in the frequency of micronuclei in Ehrlich ascites tumor cells.
    Quintana E; Pertusa J; González R; Renau-Piqueras J
    Mutat Res; 1994 Jul; 322(1):55-60. PubMed ID: 7517504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pattern of toxicity by titanocene dichloride in mice: hematologic parameters.
    Köpf-Maier P; Gerlach S
    Anticancer Res; 1986; 6(2):235-40. PubMed ID: 3707061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Tumor inhibition by metallocenes: effect of titanocene, zirconocene, and hafnocene dichlorides on Ehrlich ascites tumor in mice (author's transl)].
    Köpf-Maier P; Hesse B; Köpf H
    J Cancer Res Clin Oncol; 1980 Jan; 96(1):43-51. PubMed ID: 7188941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Titanocene modulation of cytokine imbalance induced by Ehrlich ascites tumour progression.
    Valadares MC; Klein SI; Queiroz ML
    Eur J Pharmacol; 2004 Oct; 503(1-3):203-8. PubMed ID: 15496315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Teratogenicity and embryotoxicity of titanocene dichloride in mice.
    Köpf-Maier P; Erkenswick P
    Toxicology; 1984 Nov; 33(2):171-81. PubMed ID: 6506085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitumor metallocenes: new developments and toxicologic features.
    Köpf-Maier P; Köpf H
    Anticancer Res; 1986; 6(2):227-33. PubMed ID: 3707060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ionic titanocene complexes: a new type of antitumor agent.
    Köpf-Maier P; Neuse E; Klapötke T; Köpf H
    Cancer Chemother Pharmacol; 1989; 24(1):23-7. PubMed ID: 2720888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of three newly synthesized pyrimidine-containing compounds on micronucleus induction and tumor growth.
    Nersesyan A; Muradyan R; Arsenyan F
    J BUON; 2007; 12(4):521-7. PubMed ID: 18067211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of titanocenedichloride in human renal cell carcinoma compared to conventional antineoplastic agents.
    Kurbacher CM; Nagel W; Mallmann P; Kurbacher JA; Sass G; Hübner H; Andreotti PE; Krebs D
    Anticancer Res; 1994; 14(4A):1529-33. PubMed ID: 7979181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pattern of toxicity by titanocene dichloride in mice. Blood and urine chemical parameters.
    Köpf-Maier P; Gerlach S
    J Cancer Res Clin Oncol; 1986; 111(3):243-7. PubMed ID: 3733855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitumor organometallics. II. Inhibitory effects of two diphenyl-antimony (III) dithiophosphorus derivatives on in vitro and in vivo Ehrlich ascites tumor.
    Socaciu C; Bara A; Silvestru C; Haiduc I
    In Vivo; 1991; 5(4):425-8. PubMed ID: 1667268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.